FDA Recalls For Oct. 30 And Nov. 6, 2013
This article was originally published in The Tan Sheet
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
CNS specialist Neuraxpharm has struck a deal with Israel’s Panaxia to market medical cannabis products in Europe, starting in Germany.
The AAM has warned the Trump administration that ‘Buy American’ requirements on medicines could limit patient access to affordable medicines and increase the risk of drug shortages during the coronavirus pandemic.
The US agency has pushed to next month a public meeting on the latest incarnation of the Medical Device User Fee Amendments. The meeting will be held remotely.